7876 related articles for article (PubMed ID: 2462749)
21. The alpha interferons: clinical overview.
Spiegel RJ
Semin Oncol; 1987 Jun; 14(2 Suppl 2):1-12. PubMed ID: 3296210
[TBL] [Abstract][Full Text] [Related]
22. Update on the antitumor activity of alpha interferon.
Quesda JR
Oncology (Williston Park); 1988 Mar; 2(3):49-54. PubMed ID: 3079324
[TBL] [Abstract][Full Text] [Related]
23. [Interferons in the therapy of solid tumors].
Tomao S; Mozzicafreddo A; Raffaele M; Romiti A; Papò MA; Campisi C
Clin Ter; 1995; 146(8-9):491-502. PubMed ID: 8536432
[TBL] [Abstract][Full Text] [Related]
24. INTRON A (interferon alfa-2b): clinical overview.
Spiegel RJ
Cancer Treat Rev; 1985 Dec; 12 Suppl B():5-16. PubMed ID: 3914355
[No Abstract] [Full Text] [Related]
25. Alpha interferon treatment of low-grade B-cell non-Hodgkin's lymphomas, cutaneous T-cell lymphomas, and chronic lymphocytic leukemia.
Foon KA; Roth MS; Bunn PA
Semin Oncol; 1986 Sep; 13(3 Suppl 2):35-42. PubMed ID: 3532334
[TBL] [Abstract][Full Text] [Related]
26. The role of alpha interferon in the biotherapy of hematologic malignancies and AIDS-related Kaposi's sarcoma.
Mitsuyasu RT
Oncol Nurs Forum; 1988; 15(6 Suppl):7-12. PubMed ID: 3060868
[No Abstract] [Full Text] [Related]
27. Interferon alfa-2a.
Williams CD; Linch DC
Br J Hosp Med; 1997 May 7-20; 57(9):436-9. PubMed ID: 9274677
[TBL] [Abstract][Full Text] [Related]
28. Interferon in the treatment of multiple myeloma and the non-Hodgkin's lymphomas.
Wagstaff J; Scarffe JH; Crowther D
Cancer Treat Rev; 1985 Dec; 12 Suppl B():39-44. PubMed ID: 2421896
[No Abstract] [Full Text] [Related]
29. alpha-Interferon in hematological malignancies.
Giles FJ; Ozer H
Curr Opin Biotechnol; 1991 Dec; 2(6):847-50. PubMed ID: 1367959
[TBL] [Abstract][Full Text] [Related]
30. Innovative treatment strategies for non-Hodgkin's lymphoma and multiple myeloma.
Borden EC
Semin Oncol; 1994 Dec; 21(6 Suppl 14):14-22. PubMed ID: 7992095
[TBL] [Abstract][Full Text] [Related]
31. Clinical uses for interferon in the treatment of cancer. A critical review.
Ringenberg QS; Patterson WP
Mo Med; 1988 Jan; 85(1):21-6. PubMed ID: 3277031
[No Abstract] [Full Text] [Related]
32. Interferon treatment of human neoplasia.
Strander H
Adv Cancer Res; 1986; 46():1-265. PubMed ID: 2425561
[No Abstract] [Full Text] [Related]
33. [Use of interferon in patients with hairy cell leukemia and myeloproliferative disorders].
Skotnicki AB; Wolska-Smoleń T
Acta Haematol Pol; 1994; 25(2 Suppl 1):124-35. PubMed ID: 8067197
[TBL] [Abstract][Full Text] [Related]
34. [Possibilities and limits of the use of interferons in the clinic].
Ludwig CU
Schweiz Med Wochenschr; 1989 Nov; 119(44):1539-43. PubMed ID: 2479977
[TBL] [Abstract][Full Text] [Related]
35. Interferon-alpha: current status and future promise.
Bonnem EM; Spiegel RJ
J Biol Response Mod; 1984 Dec; 3(6):580-98. PubMed ID: 6392483
[No Abstract] [Full Text] [Related]
36. Alfa interferon: combinations with other antineoplastic modalities.
Bonnem EM
Semin Oncol; 1987 Jun; 14(2 Suppl 2):48-60. PubMed ID: 3296212
[TBL] [Abstract][Full Text] [Related]
37. [Interferon-alpha therapy in non-Hodgkin's lymphoma].
Fridrik MA
Wien Med Wochenschr; 1993; 143(16-17):429-34. PubMed ID: 8273367
[TBL] [Abstract][Full Text] [Related]
38. [Interferons. Treatment of malignant hemopathies with interferons].
Guilhot F; Sadoun A; Delwail V
Ann Med Interne (Paris); 1993; 144(8):548-56. PubMed ID: 7513980
[TBL] [Abstract][Full Text] [Related]
39. Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation.
Baron F; Gothot A; Salmon JP; Hermanne JP; Pierard GE; Fillet G; Beguin Y
Br J Haematol; 2000 Dec; 111(3):745-53. PubMed ID: 11122133
[TBL] [Abstract][Full Text] [Related]
40. Chronic lymphoid leukemias: recent advances in biology and therapy.
Foon KA
Stem Cells; 1995 Jan; 13(1):1-21. PubMed ID: 7719244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
